Eledon Pharmaceuticals, Inc. Logo

Eledon Pharmaceuticals, Inc.

Clinical-stage biotech developing therapies for organ and autoimmune diseases.

ELDN | US

Overview

Corporate Details

ISIN(s):
US67011N2045 (+1 more)
LEI:
Country:
United States of America
Address:
19800 MACARTHUR BLVD., 92612 IRVINE

Description

Eledon Pharmaceuticals, Inc. is a clinical-stage biotechnology company developing immune-modulating therapies for organ transplantation and autoimmune diseases. The company's mission, "One Transplant for Life," focuses on improving transplant longevity and the quality of life for recipients. Its lead product candidate, tegoprubart, is an anti-CD40 Ligand (CD40L) antibody designed to regulate the immune system to prevent organ rejection. Eledon has completed a Phase 2 clinical trial evaluating tegoprubart in kidney transplant recipients and is advancing the compound into late-stage development. The company is also exploring tegoprubart's potential in other applications, including liver transplantation and xenotransplantation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-02 17:30
8-K
English ZIP 119.0 KB
2025-11-24 21:28 English ZIP 13.1 KB
2025-11-14 23:11
8-K
English ZIP 152.3 KB
2025-11-14 23:05
10-Q
English ZIP 1.9 MB
2025-11-13 02:55
8-K
English ZIP 352.3 KB
2025-11-13 02:52
424B5
English ZIP 256.3 KB
2025-11-12 12:03
424B5
English ZIP 256.3 KB
2025-11-07 00:44
8-K
English ZIP 121.5 KB
2025-08-14 23:11
10-Q
English ZIP 1.8 MB
2025-08-14 23:08
10-Q/A
English ZIP 1.8 MB
2025-08-14 22:46
10-K/A
English ZIP 6.8 MB
2025-08-14 22:30
8-K
English ZIP 157.5 KB
2025-08-06 22:03
8-K
English ZIP 114.4 KB
2025-07-29 19:13 English ZIP 8.2 KB
2025-07-18 01:54 English ZIP 12.5 KB

Automate Your Workflow. Get a real-time feed of all Eledon Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eledon Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eledon Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.